B Cell Activation and Differentiation
Special Features of Adaptive Immunity
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 23, 2025

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
Long Jiang1, Huajing Liu1, Chuixiu Huang2
1State Key Laboratory of Environment Health (Incubation), Key Laboratory of Environment and Health, Ministry of Education, Key Laboratory of Environment and Health (Wuhan), Ministry of Environmental Protection, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Scientists engineered red blood cells (RBCs) to lack immunogenic blood group antigens. This novel antigen-shielded RBC technology prevents transfusion reactions and addresses blood shortages, preserving RBC function.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: